← Open Payments lookup

ALEXA HAMMOCK: Open Payments

NPI 1851152409 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,779 in 116 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,784 · 2025 $1,779

Food & beverage: $1,779
CompanyPaymentsAmount
ABBVIE INC.34$401
Lilly USA, LLC11$205
Novo Nordisk Inc14$194
PFIZER INC.12$159
AstraZeneca Pharmaceuticals LP7$147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$139
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$138
Takeda Pharmaceuticals U.S.A., Inc.3$60
Actelion Pharmaceuticals US, Inc.2$45
Boehringer Ingelheim Pharmaceuticals, Inc.3$45

Products named: QULIPTA, CAPLYTA, XIFAXAN, VRAYLAR, MOUNJARO, Ozempic, UBRELVY, NURTEC ODT.

Industry payments across VA — which companies pay providers there.